chr3-122610587-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001113523.3(PARP15):āc.400C>Gā(p.Gln134Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000000715 in 1,399,468 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 32)
Exomes š: 7.1e-7 ( 0 hom. )
Consequence
PARP15
NM_001113523.3 missense
NM_001113523.3 missense
Scores
1
9
9
Clinical Significance
Conservation
PhyloP100: 5.22
Genes affected
PARP15 (HGNC:26876): (poly(ADP-ribose) polymerase family member 15) Enables NAD+ binding activity; pentosyltransferase activity; and transcription corepressor activity. Involved in negative regulation of transcription by RNA polymerase II; protein mono-ADP-ribosylation; and protein poly-ADP-ribosylation. Predicted to be active in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PARP15 | NM_001113523.3 | c.400C>G | p.Gln134Glu | missense_variant | 3/12 | ENST00000464300.7 | NP_001106995.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PARP15 | ENST00000464300.7 | c.400C>G | p.Gln134Glu | missense_variant | 3/12 | 1 | NM_001113523.3 | ENSP00000417214.2 | ||
PARP15 | ENST00000483793.5 | c.400C>G | p.Gln134Glu | missense_variant | 3/9 | 1 | ENSP00000417785.1 | |||
PARP15 | ENST00000465304.5 | n.376C>G | non_coding_transcript_exon_variant | 4/14 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000637 AC: 1AN: 156924Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 83070
GnomAD3 exomes
AF:
AC:
1
AN:
156924
Hom.:
AF XY:
AC XY:
0
AN XY:
83070
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 7.15e-7 AC: 1AN: 1399468Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 690228
GnomAD4 exome
AF:
AC:
1
AN:
1399468
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
690228
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2021 | The c.400C>G (p.Q134E) alteration is located in exon 3 (coding exon 3) of the PARP15 gene. This alteration results from a C to G substitution at nucleotide position 400, causing the glutamine (Q) at amino acid position 134 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;T
M_CAP
Benign
T
MetaRNN
Uncertain
D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
PrimateAI
Benign
T
PROVEAN
Uncertain
D;N
REVEL
Benign
Sift
Pathogenic
D;T
Sift4G
Uncertain
D;D
Polyphen
1.0
.;D
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at